参考文献
[1] Lowe S A，Bowyer L，Lust K，et al.The SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014[J].Aust N Z J Obstet Gynaecol，2015，55（5）：e1-e29.
[2] American College of Obstetricians and Gynecologists.Gestational hypertension and preeclampsia：ACOG practice bulletin，Number 222[J].Obstet Gynecol，2020，135（6）：e237-e260.
[3] Brown M A，Magee L A，Kenny L C，et al.The hypertensive disorders of pregnancy：ISSHP classification，diagnosis，and management recommendations for international practice[J].Hypertension，2018，72（1）：24-43.
[4] 杨孜，张为远.管控妊娠期高血压产科医师不该局限在自我意识范畴内谈管控妊娠期高血压认知重点[J].中华妇产科杂志，2021，56（11）：753-759.
[5] World Health Organization.WHO recommendations：drug treatment for severe hypertension in pregnancy[M].Geneva：World Health Organization，2018.
[6] Magee L A，Singer J，von Dadelszen P，CHIPS study group.Less-tight versus tight control of hypertension in pregnancy[J].N Engl J Med，2015，372（24）：2367-2368.
[7] Magee L A，von Dadelszen P，Singer J，et al.The CHIPS randomized controlled trial（control of hypertension in pregnancy study）：is severe hypertension just an elevated blood pressure？[J].Hypertension，2016，68（5）：1153-1159.
[8] American College of Obstetricians and Gynecologists.ACOG committee opinion No.767：emergent therapy for acute-onset，severe hypertension during pregnancy and the postpartum period[J].Obstet Gynecol，2019，133（2）：e174-e180.
[9] 中华医学会妇产科学分会妊娠期高血压疾病学组.妊娠期高血压疾病诊治指南（2020）[J].中华妇产科杂志，2020，55（4）：227-238.
[10] Altman D，Carroli G，Duley L，et al.Do women with pre-eclampsia，and their babies，benefit from magnesium sulphate？The Magpie Trial：a randomised placebo-controlled trial[J].Lancet，2002，359（9321）：1877-1890.
[11] 杨孜.重视妊娠期高血压疾病的规范化诊断与处理[J].实用妇产科杂志，2020，36（12）：881-885.
[12] 杨宝峰，陈建国.药理学[M].9版.北京：人民卫生出版社，2018.
[13] Graham N M，Gimovsky A C，Roman A，et al.Blood loss at cesarean delivery in women on magnesium sulfate for preeclampsia[J].J Matern Fetal Neonatal Med，2016，29（11）：1817-1821.
[14] Okusanya B O，Oladapo O T，Long Q，et al.Clinical pharmacokinetic properties of magnesium sulphate in women with pre-eclampsia and eclampsia[J].BJOG，2016，123（3）：356-366.
[15] National Institute for Health and Care Excellence.Hypertension in pregnancy：diagnosis and management（NICE guideline NG133）[Z].London：National Institute for Health and Care Excellence，2019.
[16] Balogun O A，Sibai B M.Counseling，management，and outcome in women with severe preeclampsia at 23 to 28 weeks'gestation[J].Clin Obstet Gynecol，2017，60（1）：183-189.
[17] Mounier-Vehier Claire，Amar Jacques，Boivin Jean-Marc，et al.Hypertension and pregnancy：expert consensus statement from the french society of hypertension，an affiliate of the french society of cardiology[J].Fundam Clin Pharmacol，2017，31：83-103.
[18] Ministry of Health.Diagnosis and treatment of hypertension and pre-eclampsia in pregnancy in New Zealand：a clincial practice guideline[Z].Wellington：Ministry of Health，2018.
[19] Harper L M，Biggio J R，Anderson S，et al.Gestational age of delivery in pregnancies complicated by chronic hypertension[J].Obstet Gynecol，2016，127（6）：1101-1109.
[20] CífkováR，Johnson M R，Kahan T，et al.Peripartum management of hypertension：a position paper of the ESC council on hypertension and the european society of hypertension[J].Eur Heart J Cardiovasc Pharmacother，2020，6（6）：384-393.
[21] Behrens I，Basit S，et al.Risk of post-pregnancy hypertension in women with a history of hypertensive disorders of pregnancy：nationwide cohort study[J].BMJ，2017，358：j3078.
[22] Stuart J J，Tanz L J，Missmer S A，et al.Hypertensive disorders of pregnancy and maternal cardiovascular disease risk factor development：an observational cohort study[J].Ann Intern Med，2018，169（4）：224-232.
[23] Grandi S M，Vallée-Pouliot K，Reynier P，et al.Hypertensive disorders in pregnancy and the risk of subsequent cardiovascular disease[J].Paediatr Perinat Epidemiol，2017，31（5）：412-421.